Dr. Barbara E. Drevlow, MD

Dr. Drevlow practices at Northshore University Healthsystem Faculty Practice Associates in Glenview, Illinois.

Dr. Drevlow's NPI, 1487676664, was assigned on July 24, 2006. Dr. Drevlow graduated from University Of Minnesota Medical School in 1987. Dr. Drevlow holds Illinois license 036079447.

Dr. Drevlow's primary practice is Northshore University Healthsystem Faculty Practice Associates, at 2150 Pfingsten Rd, Glenview, IL 60026 in Cook County. The practice phone is (847) 570-5235.

Dr. Drevlow's primary practice is Northshore University Healthsystem Faculty Practice Associates in Glenview, Illinois. Dr. Drevlow is also affiliated with Northwestern Medicine Central DuPage Hospital. The medical group on file is Endeavor Health Medical Group. Dmand AI also links Dr. Drevlow to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Drevlow practices, 6 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Drevlow's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Drevlow is board certified in rheumatology by the American Board of Internal Medicine. Dr. Drevlow is licensed in Illinois.

Dmand AI lists arteritis, arthritis, fibromyalgia and chronic pain, fluid in a joint, gout, joint arthropathy, joint pain and lupus among the conditions Dr. Drevlow treats.

CMS data shows 1,410 Medicare services from Dr. Drevlow across 6 procedure codes in 2024, for 416 Medicare patients. Medicare paid $77,894 for them.

CMS counts 416 Medicare patients who saw Dr. Drevlow in 2024. The largest group is 75 to 84, with 174 patients. 75% of them have arthritis, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Drevlow's median patient age at 73, with 82% women.

In 2024, Dr. Drevlow wrote 2,234 Medicare Part D claims for 386 patients. 82% of them were for generic drugs. CMS names the drug for 1,972 of them, across 40 drugs with 11 or more claims each, at $1,774,025 in total drug cost. In 2023, CMS named 1,991 claims across 43 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Drevlow for performance year 2024, reported as part of a group. Dr. Drevlow accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Drevlow as offering telehealth.

Dmand AI links 4 papers to Dr. Drevlow, published from 2015 to 2021. The most frequent topics are Arthritis, Rheumatoid. Dr. Drevlow's most frequent co-authors are Elie Akl, MD, Jeffrey David Brow, DO and Jeffrey R. Curtis, MD.

CMS Open Payments shows 2 general payments to Dr. Drevlow from 1 drug or device company from 2017 to 2018. Food and beverage make up the largest share, 100% of the total. Celgene Corporation paid the most, $241.

Dmand AI lists 3 awards for Dr. Drevlow, most recently CMS Stage 1 EHR in 2013.

Dr. Drevlow graduated from University Of Minnesota Medical School in 1987. Dr. Drevlow is a member of ACR.

Dr. Drevlow is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Cigna. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.